Company ProfilePremium

EDAP TMS

Company Profile Analysis

ESOMAR 23 Corporate BadgeISO Certifications Badge
EDAP TMS - Healthcare showcase

Year Founded & Workforce

1979

500 Employees

Industry

Healthcare

Services

Tumor Ablation
E

EDAP TMS Employee Contacts

7 verified contactsNames, job titles, seniority and locations

View Employee Contacts

EDAP TMS Overview

Company Headquarters: Vaulx-en-Velin, France

Founded: 1979

Workforce: ~ 500

Company Working: EDAP TMS is a pioneer and a market leader in Extracorporeal ShockWave Lithotripsy (ESWL) with the Sonolith range of devices. Its products are marketed through a network of subsidiaries and distribution partners around the globe. It is investing in R&D heavily to maintain and strengthen its level of innovation and research. It also offers three HIFU products such as the Ablatherm, Ablatherm Fusion, and Focal One. Products including lasers, micro-ultrasound equipment, and other medical supplies are sold by its distribution division to support its international activities. The company has operations in France, the US, and other regions.

Strategy

EDAP TMS’s business strategy is to leverage its therapeutic ultrasound expertise and its urology position to become a leader in the development, production, marketing, and distribution of minimally invasive medical devices for urology and other indications, primarily using HIFU and shockwave technologies.

Company Snapshot

$50.3M

Revenue

500

Employees

1979

Founded

Vaulx-en-Velin, France

Headquarters

SWOT Analysis

Strengths

  • High R&D investment
  • High-quality products and services
  • Strong sales and marketing strategies

Weaknesses

  • Legal disputes with other key players might affect the market share of the company

Opportunities

  • Obtaining and maintaining government regulatory approval
  • Collaboration with OEM manufacturers

Threats

  • Increasing competition in the market
  • Foreign currency exchange rate risk

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Product Offering

  • EDAP TMS
    • Tumor Ablation

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

By Business Segment: Sales fell from USD 50.3 Mn in 2019 to USD 49.9 Mn in 2021.
EDAP TMS — By Business Segment
Series (USD Mn)201920202021
Sales50.351.249.9
R&D Expenditure4.15.43.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.